drugset
drugset / Trial / NCT02538874

A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body

NCT02538874 ↗

Phase 1 Completed 275 enrolled Bristol-Myers Squibb
RandomizedParallel-groupTriple-blindBasic science

Summary

The purpose of this study is to assess safety, to measure blood levels of drug, and to find out what the drug does to the body.

Timeline

Start
2015-10-31
Primary completion
2016-11-04
Completion
2016-11-05

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-986171 Unknown — —

Indications

metabolic dysfunction-associated steatohepatitis